TAG:
lab test
Several Major Surprises Mark Events of 2002
By Robert Michel | From the Volume IX No. 17 – December 9, 2002 Issue
CEO SUMMARY: It was a year when the two blood brothers got much bigger and expanded market share by buying their largest competitors. With patient safety as the goal, employers began active steps to force hospitals, physicians, and other healthcare providers to use quality management syst…
Docs’ In-Office Testing Showing Mixed Trends
By Robert Michel | From the Volume IX No. 17 – December 9, 2002 Issue
CEO SUMMARY: Despite the burdens of CLIA certification and reduced reimbursement for lab tests, many medical practice experts are advising doctors to expand in-office testing. However, diagnostic technologies for near-patient testing are still not robust enough to support this trend. Earl…
It’s a Feud in North Carolina! LabCorp Versus Spectrum
By Robert Michel | From the Volume IX No. 17 – December 9, 2002 Issue
OVER IN NORTH CAROLINA, one of those good, old-fashioned southern feuds is under way. Like the fabled feud between the Hatfields and the McCoys of years past, Spectrum Laboratory Network and Laboratory Corporation are in a full-fledged shoot-out over market share of…
Why DIANON Sale Alters Anatomic Path Market
By Robert Michel | From the Volume IX No. 16 – November 18, 2002 Issue
CEO SUMMARY: By acquiring DIANON Systems, LabCorp raises the level of competition for tissue specimens originating in physicians’ offices. LabCorp’s acquisition is also a validation of predictions that cancer diagnostics will be a high-growth segment of laboratory medicine. Anatomic p…
“Direct-to-Consumer” Ad Runs in New York Times
By Robert Michel | From the Volume IX No. 16 – November 18, 2002 Issue
CEO SUMMARY: Two pioneering advertising campaigns launched in September. Both Myriad Genetics and IMPATH targeted consumers with advertisements about diagnostic testing. In each case, the most vocal response to the advertising came from within the medical community. Within the pathology p…
OraSure, Abbott, CDC, American Cancer Society
By Robert Michel | From the Volume IX No. 16 – November 18, 2002 Issue
Editors Note: There’s increasing pressure for the American healthcare system to deliver improved healthcare out- comes in a cost-effective manner. Not surprisingly, laboratory testing is recognized as a high-impact, low-cost way to accomplish both goals. Here’s a sampling of important healthc…
“November 18, 2002 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume IX No. 16 – November 18, 2002 Issue
Antitrust regulators are signaling displeasure about a growing number of business activities in healthcare. Timothy Muris, Chairman of the Federal Trade Commission (FTC), was in Chicago on November 7 to address a group of lawyers and business people. He told them that the FTC “cont…
Why Do Michigan Hospital Labs “Have it Together?
By R. Lewis Dark | From the Volume IX No. 15 – October 28, 2002 Issue
WHAT MAKES HOSPITAL LABORATORY ADMINISTRATORS AND PATHOLOGISTS in Michigan so willing to be both innovative and collaborative in creating sophisticated and financially successful regional laboratory organizations? As you will read on pages 2-6, Michigan Co-Tenancy Laboratory (MCL), …
Hospitals in Michigan Build Unique Shared Lab
By Robert Michel | From the Volume IX No. 15 – October 28, 2002 Issue
CEO SUMMARY: This operational model for a collaborative regional laboratory organization makes “profit” irrelevant. Serving 30 hospitals in four Midwestern states, Michigan Co-Tenancy Laboratories is consistently expanding lab testing services, lowering costs, and emphasizing the labo…
Major Changes at Dade Behring Soon to Be Visible In Lab Market
By Robert Michel | From the Volume IX No. 15 – October 28, 2002 Issue
Its recent financial restructuring now complete, Dade Behring prepares a “brand building” campaign CEO SUMMARY: Dade Behring is poised to become a tough and high-profile competitor in the laboratory diagnostics marketplace. Earlier this month,…
CURRENT ISSUE

Volume XXXII, No. 13 – September 15, 2025
The Dark Report examines a new bill that would reform PAMA and avoid reimbursement rate cuts scheduled for January 2026. Clinical laboratory leaders are urged to make their voices heard in Congress. Also, an expert describes how labs can fix pre-analytical errors and avoid disaster.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized